China Pharma Holdings (CPHI) Interest Coverage Ratio (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Interest Coverage Ratio came in at 54.32 in Q2 2026, down 127.9% on a YoY basis from 194.72 in Q2 2025, and down 26.56% quarter-over-quarter from 42.92 in Q1 2026.
Powered by 
Analysis
China Pharma Holdings (CPHI) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has reported Interest Coverage Ratio for 17 consecutive years, with 54.32 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest Coverage Ratio fell 127.9% year-over-year to 54.32; the trailing twelve-month figure through Jun 2026 stood at 66.26 (down 23.89% YoY), and the FY2025 full-year result was 118.77, up 29.2% from the prior year.
- Interest Coverage Ratio slipped to 54.32 in Q2 2026 per CPHI's latest filing, from 42.92 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 4.69 in Q4 2023 and bottomed at 203.08 in Q2 2024.
- Historically, Interest Coverage Ratio has averaged 62.99 across 5 years, with a median of 25.45 in 2025.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio soared 138.55% in 2023, then tumbled 6026.77% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 12.16 in 2022, then jumped by 138.55% to 4.69 in 2023, then tumbled by 3852.42% to 175.84 in 2024, then grew by 0.78% to 174.47 in 2025, then soared by 68.87% to 54.32 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 54.32, 42.92, and 174.47 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 10.28 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 3.65 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -21.24 |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 1,199.14 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 114.07 |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 | -54.32 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -54.32 |
| Mar 31, 2026 | -42.92 |
| Dec 31, 2025 | -174.47 |
| Sep 30, 2025 | -92.40 |
| Jun 30, 2025 | -23.84 |
| Mar 31, 2025 | -27.07 |
| Dec 31, 2024 | -175.84 |
| Sep 30, 2024 | -158.59 |
| Jun 30, 2024 | -203.08 |
| Mar 31, 2024 | -133.61 |
| Dec 31, 2023 | 4.69 |
| Sep 30, 2023 | -10.77 |
| Jun 30, 2023 | -3.31 |
| Mar 31, 2023 | -5.00 |
| Dec 31, 2022 | -12.16 |
| Sep 30, 2022 | -6.62 |
| Jun 30, 2022 | -7.08 |
| Mar 31, 2022 | -7.33 |
| Dec 31, 2021 | -1.95 |
| Sep 30, 2021 | -11.75 |